Immune Checkpoint Inhibitors in Advanced Soft Tissue Sarcomas: Current Role, Clinical Evidence, and Future Directions

Surgical Oncology Clinics of North America · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles